• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

CHIME-KLAS Report Reveals 10 Key EMR Interoperability Trends

Share:

January 27, 2021

Highlights on this story:
  • New CHIME-KLAS interoperability report reveals steady progress in some areas related to interoperability and leaps forward in others.
  • A total of 67% of provider organizations reported they often or nearly always had access to needed records in 2020, up from 28% in 2017. Providers noted improvements in functionality and usability for tasks like locating and viewing records.

Both providers and the companies that produce the hardware and software needed to exchange and use electronic health information continue to make progress in their efforts to advance healthcare IT interoperability, according to a white paper released today by the College of Healthcare Information Management Executives (CHIME) and KLAS Research.

Providers Cite Steady Progress in Interoperability

The report reveals providers cited steady progress in some areas related to interoperability and leaps forward in others. CHIME-KLAS cites a total of 67% of provider organizations reported they often or nearly always had access to needed records in 2020, up from 28% in 2017. Providers noted improvements in functionality and usability for tasks like locating and viewing records. Vendor support of data sharing improved between 2016 and 2020, with the biggest gains between partnering organizations using different EMRs. Overall, providers were increasingly optimistic that these changes will allow record exchange to have a greater impact on patient care in the future.

“For digital health to reach its full potential, we need to be able to safely and securely exchange information across the healthcare ecosystem,” said CHIME President and CEO Russell P. Branzell. “Interoperability is the linchpin. With the Cures Act and other federal initiatives promoting data sharing, we should see even more gains that ultimately will improve patient care. As is evident in the survey results, great strides have been made resulting in remarkable improvements. This required hard work for all parties involved and they should be congratulated on their collective efforts.”

10 Key Trends in EMR Interoperability

The report highlights the following 10 EMR interoperability trends in the industry based on data from a 2020 interoperability survey, with comparisons to results from past surveys.

1. Deep Interoperability Is Progressing, with Many Organizations Poised for Significant Progress in Coming Years.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The rate of provider organizations achieving deep interoperability has doubled since 2017. The overall rate leaves much to be desired, but signs of progress are visible.

2. Almost All EMR Vendors Have Improved Connections to Outside EMR Solutions

The biggest gains have come because of vendor proactivity; vendors who take an active role in helping push provider organizations to success have seen the most progress.

3. Ambulatory Clinics and Smaller Hospitals Are Connecting More Than Ever Before

KLAS market share data has shown a steady trend of EMR vendor consolidation over the past several years. Interestingly, this consolidation has resulted in more needed connections with critical exchange partners, not fewer.

4. High Costs and Lack of EMR Vendor Technical Readiness Make Interoperability Harder for Half of Surveyed Providers

The most mentioned barrier to success was cost. Buying the latest features and functionality, paying for new interfaces and connections, and the cost to keep up system customization are frequent complaints.

5. National Networks Have Reached a Tipping Point

Today, perceived value and adoption are higher than ever before, and organizations leveraging these networks are significantly more likely to report achieving deep interoperability.

6. App Use Still in Early Stages; Patient-Facing App Use Growing

Patient-facing apps are some of the most commonly used across the healthcare app landscape. Some provider organizations are leveraging apps from their vendor. Apple is the most common third party being leveraged for this use case.

7. FHIR Adoption Begins to Take Hold in Large Health Systems

The bulk of FHIR adoption comes from customers of large EMR vendors, and these organizations are are primarily leveraging FHIR APIs for patient-record exchange, clinician-enabling tools, and patient-facing tools.

8. Intended ROI of FHIR Unclear for Many

Organizations question the value of FHIR because of three primary concerns: (1) lack of patient adoption of apps, (2) an unclear connection between use-case adoption and the intended outcomes, and (3) difficulty quantifying the potential outcomes they have identified.

9. Proprietary API Adoption Is Proving Valuable

Patient-facing tools, clinician-enabling tools, and patient-record exchange are the primary use cases for proprietary APIs—just like with FHIR.

10. Robust Record Exchange and Population Health Are Top Needs Going Forward

When asked what interoperability use cases their vendor should focus on in the next two to three years, provider organizations primarily spoke about enhancements to patient-record exchange.

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Catalyst Pharmaceuticals Acquires Exclusive North American License For Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals.Catalyst Pharmaceuticals Acquires Exclusive North American License For Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals.
  • Schweiger Dermatology Group Acquires Windsor Dermatology in East Windsor, New JerseySchweiger Dermatology Group Acquires Windsor Dermatology in East Windsor, New Jersey
  • Google Maps Feature Lets Users Check how Crowded Public Transit is to Help Maintain Social DistancingGoogle Maps Feature Lets Users Check how Crowded Public Transit is to Help Maintain Social Distancing
  • XVIVO Completes the Acquisition of Star Teams Inc.XVIVO Completes the Acquisition of Star Teams Inc.
  • DispatchHealth Expands Service Line, Offers Hospital-at-Home CareDispatchHealth Expands Service Line, Offers Hospital-at-Home Care
  • Clinical Trial Software Startup Florence Healthcare Raises $27MClinical Trial Software Startup Florence Healthcare Raises $27M
  • Merck Animal Health Completes Acquisition of Vaki to Further Broaden Its Leadership Position in Aquaculture to Advance Fish Health and WelfareMerck Animal Health Completes Acquisition of Vaki to Further Broaden Its Leadership Position in Aquaculture to Advance Fish Health and Welfare
  • Only 15% of US Consumers Used A Telecare Service in Past 12 MonthsOnly 15% of US Consumers Used A Telecare Service in Past 12 Months

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications